RxDoctor Payments Data

Brandon Rickertsen, DO

Family Medicine · Maquoketa, IANPI 1639519531

Payments from drug & device makers

$602in general payments, 2019–2025

Across 33 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$198
  • Johnson & Johnson$111
  • AbbVie$71
  • Novo Nordisk$63
  • Lilly USA, LLC$45
  • AstraZeneca$35
  • plus $80 from 5 others

What the payments were for

  • Food & beverage$602100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$602 in reported general payments places this provider in the 75th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$149,240
Medicare patients
455
Services billed
3,857

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin69$71,396
EliquisApixaban104$68,958
OzempicSemaglutide56$67,713
TrulicityDulaglutide41$59,336
MounjaroTirzepatide43$48,985
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$45,983
JanuviaSitagliptin Phosphate31$41,137
FarxigaDapagliflozin Propanediol39$35,753
TradjentaLinagliptin17$20,796
Breo ElliptaFluticasone/Vilanterol39$15,383
InvokanaCanagliflozin11$14,117
XareltoRivaroxaban11$13,352
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog33$11,628
Lantus SolostarInsulin Glargine,hum.Rec.Anlog60$9,196
Novolog FlexpenInsulin Aspart33$8,081

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$45$108,32184 claims
PfizerEliquis, Paxlovid$198$70,387119 claims
Novo NordiskOzempic$63$67,71356 claims
AstraZenecaFarxiga, Symbicort$35$38,58851 claims
Johnson & JohnsonInvokana, Xarelto$111$27,46922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Maquoketa

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →